![]() |
Volumn 91, Issue 5, 2001, Pages 918-927
|
Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxirubicin, and cisplatinum closing results after 5 years of follow-up
|
Author keywords
Gastric carcinoma; Long term follow up; Neoadjuvant chemotherapy; Prognostic factors; Staging; Surgery
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
ETOPOSIDE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CARCINOMATOSIS;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ENDOSCOPIC ECHOGRAPHY;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL TOXICITY;
HUMAN;
LAPAROSCOPY;
LEUKOPENIA;
MALE;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PREOPERATIVE EVALUATION;
PRIORITY JOURNAL;
STOMACH CARCINOMA;
THROMBOCYTOPENIA;
TOTAL STOMACH RESECTION;
TUMOR CLASSIFICATION;
|
EID: 0035282174
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20010301)91:5<918::AID-CNCR1081>3.0.CO;2-W Document Type: Article |
Times cited : (115)
|
References (31)
|